Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study

Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study

Background Recent guidelines on dual antiplatelet therapy (DAPT) duration after percutaneous coronary intervention (PCI) balance the subsequent risks of major bleeding with ischemic events. Although generally favoring shorter DAPT duration with second‐generation drug‐eluting stents, the effects on l...

Full description

Bibliographic Details
Main Authors: Scott Kinlay, Melissa M. Young, Rebecca Sherrod, David R. Gagnon
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
drug‐eluting stents
dual antiplatelet therapy
duration
outcomes
percutaneous coronary interventions
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027055

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.027055

Similar Items